GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
AMAG Pharmaceuticals Inc. (AMAG) [hlAlert]

Rating:
Outperform
AMAG
up 21.23 %

AMAG Pharmaceuticals Inc. (AMAG) rated Outperform with price target $87 by Robert W. Baird

Posted on: Monday,  Feb 4, 2008  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) on 02/04/2008, when the stock price was $54.43.
Since then, AMAG Pharmaceuticals Inc. has gained 21.24% as of 01/25/2016's recent price of $65.99.
If you would have followed this Robert W. Baird's recommendation on AMAG, you would have gained 21.23% of your investment in 2912 days.

Advanced Materials Group Inc. develops, manufactures and markets a wide variety of industrial products. The company's principal subsidiary, Advanced Materials, Inc., is the successor to a business that converts specialty materials including foams, foils, films and adhesive composites into components and finished products such as printer cartridge inserts and inking felts, disk drive gaskets, automobile air conditioning insulators, water and dust seals, surgical pads and applicators for the medical, electronics, automotive and consumer products markets.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/18/2013 8:25 AM Buy
None
21.42 26.00
as of 12/24/2008
1 Week up  2.34 %
1 Month up  18.87 %
3 Months up  19.21 %
1 YTD up  18.21 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/10/2012 8:25 AM Hold
None
14.50 17.00
5/31/2011 8:25 AM Buy
None
17.40 22.00
7/29/2010 8:25 AM Hold
None
33.32 36.00
12/17/2009 10:25 AM Buy
None
37.78 55.00
2/4/2008 8:25 AM Buy
None
54.43 87.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy